262 related articles for article (PubMed ID: 24623198)
1. Bile acid sequestrants: glucose-lowering mechanisms and efficacy in type 2 diabetes.
Hansen M; Sonne DP; Knop FK
Curr Diab Rep; 2014; 14(5):482. PubMed ID: 24623198
[TBL] [Abstract][Full Text] [Related]
2. Bile acid sequestrants: glucose-lowering mechanisms.
Prawitt J; Staels B
Metab Syndr Relat Disord; 2010 Dec; 8 Suppl 1():S3-8. PubMed ID: 20977365
[TBL] [Abstract][Full Text] [Related]
3. A review of bile acid sequestrants: potential mechanism(s) for glucose-lowering effects in type 2 diabetes mellitus.
Staels B
Postgrad Med; 2009 May; 121(3 Suppl 1):25-30. PubMed ID: 19494475
[TBL] [Abstract][Full Text] [Related]
4. Beyond intestinal soap--bile acids in metabolic control.
Kuipers F; Bloks VW; Groen AK
Nat Rev Endocrinol; 2014 Aug; 10(8):488-98. PubMed ID: 24821328
[TBL] [Abstract][Full Text] [Related]
5. Bile acid sequestrants for lipid and glucose control.
Staels B; Handelsman Y; Fonseca V
Curr Diab Rep; 2010 Feb; 10(1):70-7. PubMed ID: 20425070
[TBL] [Abstract][Full Text] [Related]
6. Glucose-lowering effect of colestimide is associated with baseline HbA1c in type 2 diabetic patients with hypercholesterolemia.
Yamakawa T; Kaneko T; Shigematu E; Kawaguchi J; Kadonosono K; Morita S; Terauchi Y
Endocr J; 2011; 58(3):185-91. PubMed ID: 21350303
[TBL] [Abstract][Full Text] [Related]
7. Metabolic effects of bile acid sequestration: impact on cardiovascular risk factors.
Spinelli V; Chávez-Talavera O; Tailleux A; Staels B
Curr Opin Endocrinol Diabetes Obes; 2016 Apr; 23(2):138-44. PubMed ID: 26859552
[TBL] [Abstract][Full Text] [Related]
8. Bile acid sequestrants in type 2 diabetes: potential effects on GLP1 secretion.
Sonne DP; Hansen M; Knop FK
Eur J Endocrinol; 2014 Aug; 171(2):R47-65. PubMed ID: 24760535
[TBL] [Abstract][Full Text] [Related]
9. Bile acid sequestrants and the treatment of type 2 diabetes mellitus.
Staels B; Kuipers F
Drugs; 2007; 67(10):1383-92. PubMed ID: 17600387
[TBL] [Abstract][Full Text] [Related]
10. Bile Acid Sequestrants for Hypercholesterolemia Treatment Using Sustainable Biopolymers: Recent Advances and Future Perspectives.
Islam MS; Sharif A; Kwan N; Tam KC
Mol Pharm; 2022 May; 19(5):1248-1272. PubMed ID: 35333534
[TBL] [Abstract][Full Text] [Related]
11. The Role of Bile Acids in Glucose Metabolism and Their Relation with Diabetes.
González-Regueiro JA; Moreno-Castañeda L; Uribe M; Chávez-Tapia NC
Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):16-21. PubMed ID: 29118282
[TBL] [Abstract][Full Text] [Related]
12. Effects of bile-acid-binding resin (colestimide) on blood glucose and visceral fat in Japanese patients with type 2 diabetes mellitus and hypercholesterolemia: an open-label, randomized, case-control, crossover study.
Suzuki T; Oba K; Igari Y; Watanabe K; Matsumura N; Futami-Suda S; Ouchi M; Suzuki K; Sekimizu K; Kigawa Y; Nakano H
J Diabetes Complications; 2012; 26(1):34-9. PubMed ID: 22240263
[TBL] [Abstract][Full Text] [Related]
13. Bile acid sequestrants for glycemic control in patients with type 2 diabetes: A systematic review with meta-analysis of randomized controlled trials.
Hansen M; Sonne DP; Mikkelsen KH; Gluud LL; Vilsbøll T; Knop FK
J Diabetes Complications; 2017 May; 31(5):918-927. PubMed ID: 28238556
[TBL] [Abstract][Full Text] [Related]
14. The glucose-lowering effects of α-glucosidase inhibitor require a bile acid signal in mice.
Qiu Y; Shen L; Fu L; Yang J; Cui C; Li T; Li X; Fu C; Gao X; Wang W; Ning G; Gu Y
Diabetologia; 2020 May; 63(5):1002-1016. PubMed ID: 32034442
[TBL] [Abstract][Full Text] [Related]
15. Effect of colestimide therapy for glycemic control in type 2 diabetes mellitus with hypercholesterolemia.
Yamakawa T; Takano T; Utsunomiya H; Kadonosono K; Okamura A
Endocr J; 2007 Feb; 54(1):53-8. PubMed ID: 17102570
[TBL] [Abstract][Full Text] [Related]
16. Beyond cholesterol lowering: pleiotropic effects of bile acid binding resins against cardiovascular disease risk factors in patients with metabolic syndrome.
Yamaoka-Tojo M; Tojo T; Izumi T
Curr Vasc Pharmacol; 2008 Oct; 6(4):271-81. PubMed ID: 18855715
[TBL] [Abstract][Full Text] [Related]
17. Intestinal bile acid receptors are key regulators of glucose homeostasis.
Trabelsi MS; Lestavel S; Staels B; Collet X
Proc Nutr Soc; 2017 Aug; 76(3):192-202. PubMed ID: 27846919
[TBL] [Abstract][Full Text] [Related]
18. Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study.
Beysen C; Murphy EJ; Deines K; Chan M; Tsang E; Glass A; Turner SM; Protasio J; Riiff T; Hellerstein MK
Diabetologia; 2012 Feb; 55(2):432-42. PubMed ID: 22134839
[TBL] [Abstract][Full Text] [Related]
19. Bile acids as metabolic regulators.
Li T; Chiang JY
Curr Opin Gastroenterol; 2015 Mar; 31(2):159-65. PubMed ID: 25584736
[TBL] [Abstract][Full Text] [Related]
20. Sevelamer in a diabetologist's perspective: a phosphate-binding resin with glucose-lowering potential.
Brønden A; Hansen M; Sonne DP; Rohde U; Vilsbøll T; Knop FK
Diabetes Obes Metab; 2015 Feb; 17(2):116-20. PubMed ID: 25041567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
